$24.92
0.642.64%
At close: -
$25.01
0.090.36%
After Hours: Dec 20, 5:31 PM EDT
Royalty Pharma reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Royalty Pharma using advanced sorting and filters.
Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Sep 2024 | 2024-11-06 | $1.04 | $0.93 | 11.8 % |
Jun 2024 | 2024-08-08 | $0.96 | $0.99 | -3.03 % |
Mar 2024 | 2024-05-09 | $0.98 | $0.99 | -1.01 % |
Dec 2023 | 2024-02-15 | $1.15 | $0.99 | 16.2 % |
Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Sep 2024 | 2024-11-06 | $565.00M | $696.10M | -18.8 % |
Jun 2024 | 2024-08-08 | $537.00M | $628.26M | -14.5 % |
Mar 2024 | 2024-05-09 | $568.00M | $663.22M | -14.4 % |
Dec 2023 | 2024-02-15 | $596.00M | $673.65M | -11.5 % |
Royalty Pharma (RPRX) is scheduled to report earnings on February 13, 2025. The last reported earnings were for reported on November 6, 2024 for Q3.
The Actual EPS was $1.04, which beat the estimate of $0.93.
The Actual Revenue was $565M, which missed the estimate of $696.1M.
Browse earnings estimates, EPS, and revenue on all stocks.